ClinicalTrials.gg
WithdrawnNCT05417828Updated Oct 28, 2026

Robotic Rehabilitation for Stroke Survivors

An observational study in Chronic Stroke, sponsored by State University of New York at Buffalo. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by State University of New York at Buffalo · Observational

How we know

Why this study was withdrawn
The PI moved to another institution.
Updated Oct 28, 2026Now WithdrawnStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
0
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,995 studies in Stroke with a site in United States — 392 open to participants now, 490 under way, 17 of them phase 3. Stroke · United States.

Enrollment
351st of 363
0 · median 153
Started
2020
with 87 others
Observational
364 of 1,995
60 open now
Registered
1,504th of 1,995
by date

Among the 1,995 studies in Stroke with a site in United States, this one is the 351st largest by enrollment of the 363 observational ones that give a count, is one of 88 that started in 2020, is one of 364 observational ones, and was the 1,504th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

392 of the 1,995 studies in Stroke with a site in United States are open now. Recruiting first, the newest first:

387 more — sign in →

All 392 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,995 studies in Stroke with a site in United States, or all of them as a file.
02

Study summary

Pilot study on the physiological response of robotic rehabilitation therapy for improving the performance of activities of daily living of stroke patients

Read the detailed description

The purpose of this research is to study the feasibility of the robotic therapy that can train activities of daily living tasks for chronic stroke patients. The participant will be involved in a feasibility study (one-time visit) to prove the efficacy of the robotic device with different force feedback (assistive and resistive force) and other feedback such as VR (virtual reality). We will collect movement data from a motion capture system and sEMG sensors that measure muscle activity to monitor the effect of a robotic rehabilitation device, named Spherical Parallel Instrument for Daily Living Emulation (SPINDLE). We will use a robotic therapy device to practice activities during daily living. This pilot study will be used to understand the effect of SPINDLE to translate the device as a home-based training for chronic stroke patients.

03

Conditions studied

  • Chronic Stroke

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study participant needs to have minimal strength to move the robot. The participant needs to be able to understand the instructions during the experiment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults with chronic stroke, which affected their upper limb motor functions
  • Adults could able to understand the verbal cues during the training

Exclusion criteria

Exclusion Criteria:

  • Adults with chronic stroke, who did not lose their upper limb motor functions
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Participant with Chronic stroke

    1. Participants over 18 years of age 2. Participants should be able to understand the verbal cues during the training

    Device: Emulation of Active Daily Living tasks with a robotic device (SPINDLE)

Interventions

  • DeviceEmulation of Active Daily Living tasks with a robotic device (SPINDLE)

    SPINDLE will provide an assistive and resistive force to aid in rehabilitating the subject's upper limb

06

What researchers measure

Primary outcomes

  1. Kinematic change of the upper limb during ADLs

    The max and range of motion of shoulder, elbow, and wrist joint for each task

    Time frame: immediately after the intervention

  2. Score of activities of daily living(ADL) tasks

    We will use ARM-ULA standard score sheet to measure the performance of ADLs

    Time frame: immediately after the intervention

  3. Muscle activation change of the upper limb during ADLs

    The subject will be asked to perform activities of daily living tasks with the passive SPINDLE. Upper limb range of motion and muscle activation will be quantified.

    Time frame: immediately after the intervention

Secondary outcomes

  1. Usability measure

    Questionnaire will be provided to the user to obtain qualitative feedback

    Time frame: immediately after the intervention

07

Study locations

1 site
  • University at Buffalo, North Campus, Furnas 809
    Buffalo, New York 14260, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — The de-identified data will be shared upon request to PI.

Time frame: After the study is completed

Access criteria: The personnel who is requesting the data needs to explain how the data will be used in their research.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Aug 2020 to primary completion in May 2026, 68 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 28, 2026: start Dec 2025 → Aug 2020, primary completion Dec 2026 → May 2026 and completion Dec 2026 → May 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2022
First posted
Jun 14, 2022
StartActual
Aug 2, 2020was Dec 2025
Primary completionActual
May 1, 2026was Dec 2026
CompletionActual
May 1, 2026was Dec 2026
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Withdrawn The PI moved to another institution.
changed Oct 28, 2026
Start date
Dec 1, 2025→Aug 2, 2020 (actual)
Oct 28, 2026
Primary completion
Dec 5, 2026→May 1, 2026 (actual)
Oct 28, 2026
Study completion
Dec 5, 2026→May 1, 2026 (actual)
Oct 28, 2026
Enrollment
40 (estimated)→0 (actual)
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Not yet recruiting→Withdrawn
    Why stopped The PI moved to another institution.
    Start date Dec 1, 2025→Aug 2, 2020 (now actual)
    Primary completion Dec 5, 2026→May 1, 2026 (now actual)
    Study completion Dec 5, 2026→May 1, 2026 (now actual)
    Enrollment 40 (estimated)→0 (actual)
    + 4 other changes: index terms, verification date, responsible party and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05417828
Responsible party
Souvik Poddar (Principal Investigator, State University of New York at Buffalo) — Principal investigator
First posted
Jun 14, 2022
Start date
Aug 2, 2020
Primary completion
May 1, 2026
Completion
May 1, 2026
Last update
Oct 28, 2026

Study contacts

Jiyeon Kang
principal investigator · University at Buffalo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion